Publications Office of the EU
‘SUCCESSIVE SUPPLY OF MEDICINES USED IN MEDICINAL PROGRAMMES: - B.55 - Treatment of patients with ulcerative colitis - B.32 - Treatment of Crohn's disease" - B.33 - Treatment of active rheumatoid arthritis and juvenile idiopathic arthritis - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

‘SUCCESSIVE SUPPLY OF MEDICINES USED IN MEDICINAL PROGRAMMES: - B.55 - Treatment of patients with ulcerative colitis - B.32 - Treatment of Crohn's disease" - B.33 - Treatment of active rheumatoid arthritis and juvenile idiopathic arthritis Text automatically translated in your browsing language Automatically translated

  • Published
    11/06/2025
  • Today
    11/07/2025
  • Deadline
    16/07/2025
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
Samodzielny Publiczny Zakład Opieki Zdrowotnej w Międzychodzie
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL417 Leszczyński
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
9
Tender reference number
Not available
Description

The subject of the contract is: ‘SUCCESSIVE SUPPLY OF MEDICINES USED IN MEDICINAL PROGRAMMES: - B.55 - Treatment of patients with ulcerative colitis - B.32 - Treatment of Crohn's disease" - B.33 - Treatment of active rheumatoid arthritis and juvenile idiopathic arthritis" By successive delivery of pharmaceutical products, the Ordering Party understands the cyclical delivery of pharmaceutical products during the term of the contract in accordance with the orders placed by the Ordering Party. The contracting authority divided the subject-matter of the contract into 9 packages (lots) A detailed description of the subject-matter of the contract containing information on the assortment, quantity and requirements is set out in Annexes 3 and 3a to the EMS. The contracting authority in Annex 3 requires the contractor to provide the trade name of the medicine, the EAN code and the manufacturer of the subject-matter of the contract offered by the contractor. The Contractor may submit a tender for individual packages, whereby a given package must be offered in its entirety, the absence of any item will result in the tender being rejected as incomplete. Each of the Packages will be assessed separately, which means that the tender procedure for each Package may be decided in favour of another Contractor. The Contracting Authority will award the contract to the Contractor whose offer will meet the requirements set out in the RVU and will be considered the most advantageous, i.e. it will receive the highest number of points based on the given evaluation criteria, and its selection will be approved by the Director of the RVU in Międzychod. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://www.platformazakupowa.pl/transakcja/1122148
Tenders may be submitted
Electronic submission: required
https://www.platformazakupowa.pl/transakcja/1122148
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.